Already a Bloomberg.com user?
Sign in with the same account.
Don't have an account?
Help! I can't access my account.
Aug. 15 (Bloomberg) -- Sanofi Chief Science Officer Paul Chew discusses his company's FDA approved Auvi-Q, used for treating life-threatening allergic reactions. He speaks with Dominic Chu on Bloomberg Television's "Bottom Line." (Source: Bloomberg)
On Air Now
In The Loop with Betty Liu
Max 250 characters
©2013 Bloomberg L.P. All Rights Reserved. Made in NYC